Ascendis Pharma A/S Price/Sales
Cos'è Price/Sales di Ascendis Pharma A/S?
Price/Sales di Ascendis Pharma A/S è 188.17
Qual è la definizione di Price/Sales?
Il rapporto prezzo / vendite è il prezzo delle azioni di una società rispetto ai suoi ricavi.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Price/Sales di aziende nel Health Care settore su NASDAQ rispetto a Ascendis Pharma A/S
Cosa fa Ascendis Pharma A/S?
ascendis pharma a/s is a biotechnology company located in 12 tuborg blvd., hellerup, capital region of denmark, denmark.
Aziende con price/sales simili a Ascendis Pharma A/S
- NB Private Equity Partners ha Price/Sales di 185.33
- Novoheart ha Price/Sales di 185.90
- Chibougamau Independent Mines ha Price/Sales di 187.52
- London Finance & Investment P.L.C ha Price/Sales di 187.72
- Chemesis International ha Price/Sales di 187.93
- Mask Investments ha Price/Sales di 187.96
- Ascendis Pharma A/S ha Price/Sales di 188.17
- Australian Mines ha Price/Sales di 188.24
- New Pacific Metals ha Price/Sales di 189.25
- LQwD FinTech ha Price/Sales di 189.28
- Red Hill Iron ha Price/Sales di 189.52
- Momenta Pharmaceuticals ha Price/Sales di 190.03
- Imugene ha Price/Sales di 191.80